CD109

CD109 詳細

英語名DNA polymerase alpha subunit市販薬剤の数2
治験薬の数3ターゲットの別称P180,N Syndrome (Mental Retardation, Malformations, Chromosome Breakage),NSX,VEODS,Polymerase (DNA Directed), Alpha,POLA1,Polymerase (DNA-Directed), Alpha (70kD),DNA Polymerase Alpha 1, Catalytic Subunit,POLA,EC:2.7.7.7,EC 2.7.7.7,DNA Polymerase Alpha Catalytic Subunit,DNA Polymerase Alpha Catalytic Subunit P180,Polymerase (DNA) Alpha 1, Catalytic Subunit,DNA Polymerase I,Polymerase (DNA Directed), Alpha 1, Catalytic Subunit
研究&開発段階Approved
英語名DNA polymerase alpha subunit
ターゲットの別称P180,N Syndrome (Mental Retardation, Malformations, Chromosome Breakage),NSX,VEODS,Polymerase (DNA Directed), Alpha,POLA1,Polymerase (DNA-Directed), Alpha (70kD),DNA Polymerase Alpha 1, Catalytic Subunit,POLA,EC:2.7.7.7,EC 2.7.7.7,DNA Polymerase Alpha Catalytic Subunit,DNA Polymerase Alpha Catalytic Subunit P180,Polymerase (DNA) Alpha 1, Catalytic Subunit,DNA Polymerase I,Polymerase (DNA Directed), Alpha 1, Catalytic Subunit
市販薬剤の数2
治験薬の数3
研究&開発段階Approved

CD109 製品リスト

  • 属性

    Protein (4)

  • 製品ライブラリ

    オンライン (4)

  • Human (3)Cynomolgus (1)

  • タグ

    His Tag & Avi Tag (1)His Tag (2)Fc Tag (1)

  • マーカー

    Biotin-labeled (1)Unconjugated (3)

CD109バックグランド

CD109 is a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. CD109 is expressed in many malignant tumors, including various squamous cell carcinomas and adenocarcinomas, and plays a role as a multifunctional coreceptor.CD109 reportedly associates with transforming growth factor (TGF)-β receptors and negatively regulates TGF-β signaling in keratinocytes. Additionally, CD109 is potentially related to signal transducer and activator of transcription-3 signaling and aberrant cell proliferation.

CD109分子の別称

CD109,CPAMD7,r150,p180,CPAMD7

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Clofarabine (Boyen)BY-101Phase 3 ClinicalBoyen Therapeutics IncLeukemia, Myeloid, Acute
詳細
Alkasar-18NOAC; Alkasar-18; N4-octadecyl-ara-CPhase 1 ClinicalUniversity of ZurichCerebral Hemorrhage; Neoplasms; Atrial Fibrillation
詳細
SapacitabineCS-682; CYC-682Phase 1 ClinicalDaiichi Sankyo Co LtdLeukemia; Myelodysplastic Syndromes; Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Carcinoma, Non-Small-Cell Lung
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
ClofarabineCAFdA; JC0707; GZ-393590; SAR-393590; 2-Cl-2-F-araAApprovedGenzyme CorpClolar, Evoltra, Ivozall, ClofarexUnited StatesPrecursor Cell Lymphoblastic Leukemia-LymphomaGenzyme Corp2004-12-28Neoplasms; Angioimmunoblastic T-cell Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Lymphoproliferative Disorders; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Histiocytosis, Langerhans-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Multiple Myeloma; Leukemia; Lymphoma, Large B-Cell, Diffuse; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia, Lymphoid; Intestinal Neoplasms; Lymphoma, T-Cell, Peripheral; Lymphoma, B-Cell, Marginal Zone; Lymphoma, B-Cell; Hematologic Neoplasms; Leukemia, Myeloid; Leukemia, Myelogenous, Chronic; Solid tumours
詳細
Nelarabine506U; 506-U78; GW-506U; GW-506U78; GI-262250X; NSC-686673ApprovedNovartis Pharma Ag, Glaxosmithkline PlcArranon, ArranonG, AtrianceUnited StatesPrecursor T-Cell Lymphoblastic Leukemia-LymphomaSandoz2005-10-28Sezary Syndrome; Mycosis Fungoides; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Angioimmunoblastic T-cell Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Waldenstrom Macroglobulinemia; Lymphoma, T-Cell; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Multiple Myeloma; Leukemia-Lymphoma, Adult T-Cell; Myeloproliferative Disorders; Myelodysplastic Syndromes; Plasmacytoma; Lymphoma, B-Cell, Marginal Zone
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8